feed,title,long_url,short_url
Benzinga,Ophthalmic Biopharmaceutical Ocuphire Pharma Shifts Focus To Gene Therapy Through Opus Genetics Stock Deal,https://benzinga.com/general/biotech/24/10/41499463/ophthalmic-biopharmaceutical-ocuphire-pharma-shifts-focus-to-gene-therapy-through-opus-genetics-s,https://da.gd/WAwVX
